Skip to main content
Log in

Serum erythropoietin and transferrin in children with idiopathic nephrotic syndrome

  • Research Article
  • Published:
Frontiers of Medicine in China Aims and scope Submit manuscript

Abstract

Idiopathic nephrotic syndrome (INS) is characterized by marked urinary excretion of albumin and other intermediate-sized plasma proteins, such as transferrin and vitamin D-binding protein. Some cases even develop anemia. The aim of this study was to investigate the changes in serum iron, transferrin, and erythropoietin, and the relationships between serum and urine transferrin and erythropoietin. Thirty-seven children with INS and 35 age-and sex-matched healthy children were investigated. The indexes related to iron metabolism, including serum iron, ferritin, transferrin, total iron-binding capacity (TIBC), transferrin saturation, and hematological parameters [hemoglobin (Hb), mean corpuscular volume (MCV), mean corpuscular hemoglobin (MCH)], and urinary transferrin and erythropoietin were measured in 37 children with INS before treatment and at the remission stage. Thirty-five age-and sex-matched healthy children served as controls. Serum iron levels (18.8 ± 3.8) μmol/L in INS patients before treatment were significantly lower than those of the healthy controls (22.2 ± 3.8) μmol/L and those measured at the remission stage (21.0 ± 3.5) μmol/L (all P < 001). Serum transferrin levels in INS patients before therapy (1.9 ± 0.3) g/L also decreased compared with the healthy controls (3.1 ± 0.5) g/L and the measures at the remission stage (2.9 ± 0.6) g/L (all P < 0.01). In contrast, serum TIBC and transferrin saturation were significantly higher in INS patients before treatment than in the healthy controls [TIBC (56.4 ± 9.2) μmol/L vs (50.7 ± 6.8) μmol/L, P < 0.01; transferrin saturation (55.7 ± 9.2)% vs (46.4 ± 8.2)%, P < 0.01] and they were also higher than the measures at remission stage [(51.9 ± 7.7) μmol/L and (47.4 ± 13.3) μmol/L] (all P < 0.01). Serum transferrin was positively correlated with serum albumin (r = 0.609, P < 0.01) and negatively correlated with urinary transferrin (r = −0.550, P < 0.01) in INS patients before treatment. We conclude that serum iron, transferrin and erythropoietin levels are markedly decreased in INS patients, which may be partially related to the urinary loss of these indexes.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Grymonprez A, Proesmans W, Van Dyck M, Jans I, Goos G, Bouillon R. Vitamin D metabolites in childhood nephrotic syndrome. Pediatr Nephrol, 1995, 9(3): 278–281

    Article  PubMed  CAS  Google Scholar 

  2. Deegens J K, Wetzels J F. Fractional excretion of high-and low-molecular weight proteins and outcome in primary focal segmental glomerulosclerosis. Clin Nephrol, 2007, 68(4): 201–208

    PubMed  CAS  Google Scholar 

  3. Varghese S A, Powell T B, Budisavljevic M N, Oates J C, Raymond J R, Almeida J S, Arthur J M. Urine biomarkers predict the cause of glomerular disease. J Am Soc Nephrol, 2007, 18(3): 913–922

    Article  PubMed  CAS  Google Scholar 

  4. Cooper M A, Biddington B, Miller N L, Alfrey A C. Urinary iron specification in nephrotic syndrome. Am J Kidney Dis, 1995, 25(2): 314–319

    Article  PubMed  CAS  Google Scholar 

  5. Beard J L, Murray-Kolb L E, Rosales F J, Solomons N W, Angelilli M L. Interpretation of serum ferritin concentrations as indicators of total-body iron stores in survey populations: the role of biomarkers for the acute phase response. Am J Clin Nutr, 2006, 84(6): 1498–1505

    PubMed  CAS  Google Scholar 

  6. Sun X, Kaysen G A. Albumin and transferrin synthesis are increased in H4 cells by serum from analbuminemic or nephrotic rats. Kidney Int, 1994, 45(5): 1381–1387

    Article  PubMed  CAS  Google Scholar 

  7. Prinsen B H, de Sain-van der Velden M G, Kaysen G A, Straver H W, van Rijn H J, Stellaard F, Berger R, Rabelink T J. Transferrin synthesis is increased in nephrotic patients insufficiently to replace urinary losses. J Am Soc Nephrol, 2001, 12(5): 1017–1025

    PubMed  CAS  Google Scholar 

  8. Branten A J, Swinkels D W, Klasen I S, Wetzels J F. Serum ferritin levels are increased in patients with glomerular diseases and proteinuria. Nephrol Dial Transplant, 2004, 19(11): 2754–2760

    Article  PubMed  CAS  Google Scholar 

  9. Kemper M J, Bello A B, Altrogge H, Timmermann K, Ludwig K, Müller-Wiefel D E. Iron homeostasis in relapsing steroid-sensitive nephrotic syndrome of childhood. Clin Nephrol, 1999, 52(1): 25–29

    PubMed  CAS  Google Scholar 

  10. Castellino P, Cataliotti A. Changes of protein kinetics in nephrotic patients. Curr Opin Clin Nutr Metab Care, 2002, 5(1): 51–54

    Article  PubMed  CAS  Google Scholar 

  11. Shibasaki T, Misawa T, Matsumoto H, Abe S, Nakano H, Matsuda H, Gomi H, Ohno I, Ishimoto F, Sakai O. Characteristics of anemia in patients with nephrotic syndrome. Nippon Jinzo Gakkai Shi, 1994, 36(8): 896–901

    PubMed  CAS  Google Scholar 

  12. Cooper M A, Buddington B, Miller N L, Alfrey A C. Urinary iron specification in nephrotic syndrome. Am J Dis, 1995, 25(2): 314–319

    Article  CAS  Google Scholar 

  13. Howard R L, Buddington B, Alfrey A C. Urinary albumin, transferrin, and iron excretion in diabetic patients. Kidney Int, 1991, 40(5): 923–926

    Article  PubMed  CAS  Google Scholar 

  14. Feinstein S, Becker-Cohen R, Algur N, Raveh D, Shalev H, Shvil Y, Frishberg Y. Erythropoietin deficiency causes anemia in nephrotic children with normal kidney function. Am J Kidney Dis, 2001, 37(4):736–742

    PubMed  CAS  Google Scholar 

  15. Alfrey A C. Role of iron and oxygen radicals in the progression of chronic renal failure. Am J Kidney Dis, 1994, 23(2): 183–187

    PubMed  CAS  Google Scholar 

  16. Nankivell B J, Boadle R A, Harris D C. Iron accumulation in human chronic renal disease. Am J Kidney Dis, 1992, 20(6): 580–584

    PubMed  CAS  Google Scholar 

  17. kaysen G A, Sun X, Jones H Jr, Martin V I, Joles J A, Tsukamoyo H, Couser W G, Bander H. Non-iron-mediated alteration in hepatic transferrin gene expression in the nephrotic rat. Kidney Int, 1995, 47(4): 1068–1077

    Article  PubMed  CAS  Google Scholar 

  18. Mähr N, Neyer U, Prischl F, Kramar R, Mayer G, Kronenberg F, Lhotta K. Proteinuria and hemoglobin levels in patients with primary glomerular disease. Am J Kidney Dis, 2005, 46(3): 424–431

    Article  PubMed  CAS  Google Scholar 

  19. Terrier B, Fakhouri F, Sultanik P, Delarue R, Hummel A. Urinary erythropoietin excretion: an unknown cause of anemia during nephrotic syndrome. Rev Med Interne, 2006, 27(8): 643–645

    Article  PubMed  CAS  Google Scholar 

  20. Vaziri N D, Kaupke C J, Barton C H, Gonzales E. Plasma concentration and urinary excretion of erythropoietin in adult nephrotic syndrome. Am J Med, 1992, 92(1): 35–40

    Article  PubMed  CAS  Google Scholar 

  21. Zhou X J, Vaziri N D. Erythropoietin metabolism and pharmacokinetics in experimental nephrosis. Am J Physiol Renal Physiol, 1992, 263(5pt2): F812–F815

    CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Hongzhu Lu.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lu, H., Wang, L., Fan, Q. et al. Serum erythropoietin and transferrin in children with idiopathic nephrotic syndrome. Front. Med. China 2, 286–289 (2008). https://doi.org/10.1007/s11684-008-0054-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11684-008-0054-6

Keywords

Navigation